AOD-9604 in the United States
FDA states that AOD-9604 free base and acetate are not components of an approved drug. The largest oral obesity study failed to show a statistically significant weight-loss difference, and the 2024 advisory committee voted 0 to 12 on placing the two forms on the 503A Bulks List. A public 5 mg research vial listing is not an approved product or the historical oral trial formulation.
- Evidence lane
- Research price board
- Global identity
- US research-market identity with a failed oral obesity program and no FDA-approved drug